Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into redox mediator-enhanced laccase degradation of tetracycline and sulfamethoxazole: MD simulations and experimental validation.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

PU.1 is a mediator of the reactive stromal response associated with castration-resistant prostate cancer.

Communications biology·2026
Same author

Efficient synthesis of optically pure D-lactate from mixed sugars by engineered <i>E. coli</i> consortium.

Biodesign research·2026
Same author

Multi-cycle application of Virgibacillus dokdonensis induces a root-knot nematode-suppressive soil via specifically recruiting functional Pseudomonas.

Journal of advanced research·2026
Same author

Rapidly progressive papulonodular eruption in a febrile patient.

JAAD case reports·2026
Same author

[Screening, characterization, and application of a novel pectinase in ramie degumming].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026

Related Experiment Video

Updated: Apr 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer.

David Lluís1, Wanli Cheng2, Josep Maria Piulats3

  • 1Medical Oncology Department, Catalan Institute of Cancer (ICO), L'Hospitalet de Llobregat, Barcelona 08907, Spain; Department for BioMedical Research, Urology Research Laboratory, University of Bern, Bern 3008, Switzerland.

The Urologic Clinics of North America
|April 15, 2026
PubMed
Summary

Prostate cancer growth relies on androgen receptor signaling. Castration-resistant prostate cancer emerges due to treatment resistance, with multi-omics revealing its complex biology and adaptive mechanisms.

Keywords:
Androgen receptorCastration-resistant mechanismsProstate cancerReview

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

48.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Experiment Videos

Last Updated: Apr 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

48.3K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer progression is primarily driven by androgen receptor (AR) signaling.
  • Androgen deprivation therapy (ADT) is a standard treatment but often leads to castration-resistant prostate cancer (CRPC).
  • CRPC develops through adaptive molecular mechanisms, highlighting the need for deeper biological understanding.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying prostate cancer progression and resistance to therapy.
  • To explore the role of multi-omics approaches in deciphering CRPC biology.
  • To gain insights into the heterogeneity and adaptive strategies of castration-resistant prostate cancer.

Main Methods:

  • Utilized multi-omics approaches (genomics, transcriptomics, proteomics, etc.) to analyze CRPC samples.
  • Integrated multi-omics data to identify key molecular pathways and alterations.
  • Correlated molecular findings with clinical data to understand resistance mechanisms.

Main Results:

  • Identified specific molecular alterations and signaling pathways driving AR-dependent and AR-independent CRPC.
  • Uncovered significant heterogeneity in molecular profiles across CRPC tumors.
  • Demonstrated the utility of multi-omics in revealing adaptive mechanisms conferring treatment resistance.

Conclusions:

  • Androgen receptor signaling remains central to prostate cancer, but adaptive mechanisms drive resistance to ADT.
  • Multi-omics approaches are essential for understanding the complex biology and heterogeneity of CRPC.
  • Further research into these molecular underpinnings is critical for developing novel therapeutic strategies for advanced prostate cancer.